Streetwise Live! Presents Silver Viper Minerals on 05/12/2021. Learn More

AbbVie's Allergan Aesthetics to Acquire Soliton for $550 Million

  ()
Soliton Inc. shares traded 25% higher after the company reported it had agreed to be acquired by AbbVie Inc.'s Allergan Aesthetics for $22.60 per share in an all cash transaction. read more >

Twist Bioscience Shares Wind Higher After Firm Posts 62% YoY Increase in Q2 Revenue

  ()
Shares of Twist Bioscience Corp. traded 14% higher after the firm reported that orders in Q2/21 grew by 69% year-over-year and that it is raising its FY/21 revenue guidance to $121–129 million. read more >
News Update

Virtual Care Solutions Company Adds New Clients, Expands Care Management Team

News Update
  ()
Reliq Health Technologies reported the addition of four new skilled nursing facility customers in the southern U.S. and announced plans to expand its Care Management Team to meet the growing demand for Care Management Services. read more >

Telehealth's Transformation of Healthcare Will Outlive the Pandemic, Boost AI Applications

Contributed Research
  ()
COVID-19 brought record-setting investment to the healthcare industry in 2020, but this year is shaping up to be even better, reports McAlinden Research Partners. Demand for telehealth services skyrocketed during the pandemic, and funding is starting to follow suit. read more >

Biotech's Gene Therapy Assets Put It 'Ahead of the Pack'

Research Report
  ()
Sio Gene Therapies' focus and strategic portfolio are discussed in an H.C. Wainwright & Co. coverage initiation report. read more >
News Update

Firm Doubles in Size by Adding Four New Psychedelic Mental Health Clinics

News Update
  ()
Novamind Inc. is opening four new psychedelic mental health clinics as part of the company's national expansion strategy, giving it the capability to conduct 65,000 client visits in 2021. read more >

BioNTech Shares Gain 11% on Filing COVID-19 Vaccine Expanded Use Request to EMA in Children Ages 12 to 15

  ()
BioNTech shares established a new 52-week high price after the company reported that together with its partner Pfizer it has filed a request to expand Conditional Marketing Authorization of COMIRNATY® in the EU to adolescents ages 12 to 15 for its mRNA-based SARS-CoV-2 vaccine. read more >

CryoLife Shares Trade 18% Higher on Q1 Financial Results

  ()
Shares of CryoLife Inc. set a new 52-week high intraday price after the company reported that total revenues in Q1/21 increased by 7% YoY to $71.1 million. read more >

Galera Posts Positive Data from Phase 1/2 Pancreatic Cancer Trial

  ()
Galera Therapeutics shares traded 25% higher after the company reported new data from its Phase 1/2 pilot study of dismutase mimetic GC4419 that when used in combination with radiation therapy was shown to nearly double median overall survival time in patients with locally advanced pancreatic cancer. read more >

ADMA Biologics Granted FDA Approval to Boost IVIG Production by 50%

  ()
ADMA Biologics shares traded 9% higher after the company received FDA approval for increased intravenous immune globulin production scale, allowing the firm to increase manufacturing capacity from 400,000 to 600,000 liters and achieve peak revenues of greater than $300 million. read more >

Biopharma Study Shows Safety of Stem Cell Therapy in Severe COVID-19 Patients

Research Report
  ()
The clinical trial, in which Sorrento Therapeutics established safety, and the company's next steps for this potential treatment are summarized in a Dawson James Securities report. read more >

Aldeyra's Drug Meets All Key Endpoints in Phase 3 Allergic Conjunctivitis Trial

  ()
Aldeyra Therapeutics shares traded 33% higher after the firm reported that reproxalap significantly met all primary and secondary endpoints in its Phase 3 allergic conjunctivitis study. read more >

Ocugen Reports $100 Million Direct Share Offering at Market Premium from Institutional Investors

  ()
Ocugen Inc. shares traded up as much as 47% before closing just 3.66% higher for the day after the company announced a $100 million registered direct offering of common stock priced at a $10 per share, which represents a premium to the market price. read more >

Expert Investing Ideas

"Final results from AGN's Phase 2b COVID-19 trial are expected soon."

–André Uddin, Research Capital Corporation


"AGN is to continue a number of preclinical studies of DMT for stroke."

–André Uddin, Research Capital Corporation


"AGN [shares] are now in a vigorous uptrend."

–Clive Maund, CliveMaund.com


"Multiple players are at the table with PMN for a licensing deal."

–André Uddin, Research Capital Corporation


"PMN is to initiate a Phase 1 PMN310 study for Alzheimer's in H2/19."

–André Uddin, Research Capital Corporation


Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe
NASDAQ Biotech ARCA Pharmaceutical

Healthcare Services Group Shares Rise 13% on Q1 Earnings and Quarterly Dividend Increase

  ()
Healthcare Services Group Inc.'s shares traded 13% higher after the company reported Q1/21 financial results that included a 22% YoY increase in net income. read more >

Is the Trend Turning for This Psychedelic Stock?

Contributed Opinion
  ()
Technical analyst Clive Maund charts Delic Inc. and explains why he considers the stock attractive at this point. read more >

Merck Selects Rapidly Growing Psychedelic Medicine Company as Key Research Site

  ()
Novamind runs clinics, research sites and therapeutic retreats and is positioning itself for expansion. read more >